Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Periodontal ligament stem cells show promise for regrowing tissues but require more research for safe, effective use.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Olive oil compounds may help prevent cancer in animals, but human results are mixed.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Using human fat tissue derived stem cells in micrografts can safely and effectively increase hair density in people with hair loss.

Activating the Wnt/β-catenin pathway could lead to new hair loss treatments.

NF-κB is crucial for zebrafish heart repair, affecting heart cell growth and repair processes.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Restoring mitochondrial function in mice reversed their skin wrinkling and hair loss.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

The nude gene causes skin cell overgrowth and improper development, leading to hair and urinary issues.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Finding eosinophils near hair bulbs helps diagnose alopecia areata.

Children with atopic dermatitis often have sleep problems due to itching and may benefit from melatonin, which helps with sleep and skin symptoms.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.